e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Cystic fibrosis lung disease: what do we measure? What do we know?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tumour necrosis factor-α and lymphotoxin-α gene polymorphisms in cystic fibrosis lung disease
G. Shmarina, A. Pukhalsky, D. Pukhalskaya, L. Perederko, N. Petrova, N. Kashirskaya (Moscow, Russian Federation)
Source:
Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Session:
Cystic fibrosis lung disease: what do we measure? What do we know?
Session type:
Electronic Poster Discussion
Number:
342
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Shmarina, A. Pukhalsky, D. Pukhalskaya, L. Perederko, N. Petrova, N. Kashirskaya (Moscow, Russian Federation). Tumour necrosis factor-α and lymphotoxin-α gene polymorphisms in cystic fibrosis lung disease. Eur Respir J 2007; 30: Suppl. 51, 342
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Cystic fibrosis and intestinal organoids
Asbestosis
Related content which might interest you:
Clinical course of cystic fibrosis lung disease and tumour necrosis factor-β gene polymorphism
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
Tumor necrosis factor-α gene polymorphism and inflammatory process in cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 403s
Year: 2005
TNF gene polymorphisms and asthma development in cystic fibrosis patients
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010
Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene
Source: Eur Respir J 2002; 19: 912-918
Year: 2002
Tumour necrosis factor-α polymorphism and ozone-induced lung function change
Source: Annual Congress 2003 - Effects of outdoor air pollution in adults
Year: 2003
Tumor necrosis factor-α and interleukin-6 gene polymorphisms in pulmonary embolism
Source: Eur Respir J 2005; 26: Suppl. 49, 520s
Year: 2005
Association of the TNF gene promoter polymorphism with serum tumor necrosis factor-alpha levels in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2006; 28: Suppl. 50, 522s
Year: 2006
Early cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 77-87
Year: 2014
Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 528s
Year: 2002
Correlation of IL-1 alpha and IL-4 promotor region gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis
Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease
Year: 2006
Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
Pathophysiology of cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 1-13
Year: 2014
Factors affecting progression of lung disease among patients with cystic fibrosis
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
Tumor necrosis factor-α gene polymorphisms in COPD in a Spanish population
Source: Eur Respir J 2005; 26: Suppl. 49, 94s
Year: 2005
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD
Source: Eur Respir J 2007; 30: 810-812
Year: 2007
Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 404s
Year: 2005
Angiopoietin-2 gene polymorphism as prognostic factor in caucasians with idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 1
Year: 2014
How much genotype influences cystic fibrosis associated liver disease?
Source: Eur Respir J 2006; 28: Suppl. 50, 717s
Year: 2006
Role of vascular endotelial growth factor polymorphisms in interstitial lung disease
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept